Top Suppliers:I want be here

976-71-6

976-71-6 structure
976-71-6 structure

Name Canrenone
Synonyms lerenone IMpurity - Canrenone
CANRENONE
sc9376
17-Hydroxy-3-oxo-17-pregna-4,6-diene-21-cboxylicacid-lactone
Phanurane
4,6-ANDROSTEN-17-ALPHA-YL-PROPIONIOACID-R-LACTONE
ALDADIENE
11614r.p
3-(3-Oxo-17b-hydroxy-4,6-androstadien-17a-yl)propionic Acid g-Lactone
CANRENONE-D4
PREGNA-4,6-DIENE-17-BETA-0L-3-ONE-21-CBOXYLIC ACID-GAMMA LACTONE
7-Cboxy-9Δ-canrenone
phanurane
Canrenone Solution, 100ppm
Spironolactone Related CoMpound A
CANRENOIC ACID GAMMA LACTONE
Canrenone D7Q: What is Canrenone D7 Q: What is the CAS Number of Canrenone D7 Q: What is the storage condition of Canrenone D7 Q: What e the applications of Canrenone D7
Journal of risperidone
Canrenone 17-hydroxy-3-oxo-17a-pregna-4,6-diene-21-cboxylic acid gamma-lactone
CANRENONE[SPIRONOLACTONE INTERMEDIATE]
Pregna-4,6-diene-21-cboxylic acid, 17-hydroxy-3-oxo-, γ-lactone, (17α)
spirolactonesc14266
Luvion
lerenone Impurity 28
10,13-Dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione
Spironolactone Impurity F
17-hydroxy-3-oxo-17a-pregna-4,6-diene-21-cboxylic acid gamma-lactone
CanrenoneMin
CanrenoneQ: What is Canrenone Q: What is the CAS Number of Canrenone Q: What is the storage condition of Canrenone Q: What e the applications of Canrenone
17-hydroxy-3-oxo-,gamma-lactone,(17-alpha)-pregna-6-diene-21-cboxylicacid
Candy, ketone
(-17-Hydroxy-3-oxo-pregna-4,6-diene-21-cboxylic Acid -Lactone)
Spironolactone Impurity F (Canrenone)
Spironolactone Impurity F-d4 (Canrenone-d4)
Spironolactone Impurity 6(Spironolactone Impurity F)
Canrenone CRS
17-(2-Cboxyethyl)17-hydroxyandrosta-4,6-dien-3-onelactone
6,7-Dehydro-7α-desthioacetylspironolactone
(17α)-17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylicacidγ-lactone
RP-11614
pregna-4,6-diene-21-cboxylicacid,17-hydroxy-3-oxo-,gamma-lactone,(17-alph
Canrenone, >=
Spiranolactone Impurity F
(8R,9S,10R,13S,14S,17R)-10,13-Dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione
11614 R.P.
7-Cboxy-9&Delta
(17R)-3-Oxo-17-hydroxypregna-4,6-diene-21-cboxylic acid γ-lactone
Pregna-4,6-diene-21-cboxylicacid, 17-hydroxy-3-oxo-, g-lactone, (17a)
(17a)-17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid g-lactone
17a-(2-Carboxyethyl)-17b-hydroxyandrosta-4,6-dien-3-one Lactone
17a-(2-Carboxyethyl)-17b-hydroxy-3-oxoandrosta-4,6-diene Lactone
kanlitong
Contaren
6-Dehydrotestosterone-17a-propionic Acid g-Lactone
lerenone Canrenone Impurity
(7a)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-cboxylic Acid -Lactone
4,6-ANDROSTADIEN[(17(B-1')-SPIRO-5')]-PERHYDROFURAN-2,3-DIONE
(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione
17a-(2-Cboxyethyl-17b-hydroxyandrosta-4,6-dien-3-one Lactone
17-(2-Cboxyethyl)17-hydroxy-3-oxoandrosta-4,6-dienelactone
(17R)-17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylic acid γ-lactone
Spironolactone Related Compound A (Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21, 17-cbolactone))
17a-2-Cboxyethyl-17-hydroxyandrosta-4,6-dien-3-one Lactone
Spironolactone Related Compound A (Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21, 17-cbolactone)) (AS)
(7a)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-cboxylic Acid g-Lactone
Description Canrenone (Aldadiene; SC9376; SC14266) is an aldosterone antagonist extensively used as a diuretic agent.
Related Catalog
Target

Target: Aldosterone[1]

In Vitro Canrenone inhibits the production of eortieosterone, 18-hydroxydesoxyeortieosterone, 18-hydroxycorticosterone and aldosterone in a dose-dependent manner[1]. Canrenone dose-dependently reduces platelet-derived growth factor–induced cell proliferation and motility. Canrenone inhibits the activity of the Na+/H+ exchanger 1 induced by platelet-derived growth factor[2].
In Vivo Canrenone is the principal active metabolite of Spironolactone in the rat only for a limited period. During chronic treatment a difference developed between the effect of Spironolactone and Canrenone on the RAAS indicating a decrease in the anti-mineralocorticoid activity of Canrenone and an increase in the efficacy of Spironolactone[3].
Cell Assay Confluent Hepatic Stellate Cells (HSC) are incubated in SFIF medium for 24 hours and exposed to increasing concentrations of canrenone (1, 5, 10, 25 μM). Cell viability is evaluated by the trypan blue dye exclusion test at the end of a 24- to 48-hour incubation period[2].
Animal Admin Rats[3] Canrenone (CAN) is given orally in two different doses (10.25, 20.5 mg/mL) to Male SPF Sprague-Dawley rats for 6 weeks. To determine the Na+, K+, fluid and aldosterone excretion the urine of the rats destined to be killed after 6 weeks is collected at weekly intervals[3].
References

[1]. Erbler HC, et al. On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1973;277(2):139-49.

[2]. Caligiuri A, et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology. 2003 Feb;124(2):504-20.

[3]. Erbler HC, et al. Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats. Acta Endocrinol (Copenh). 1979 Jan;90(1):147-56.

Density 1.2±0.1 g/cm3
Boiling Point 541.1±50.0 °C at 760 mmHg
Melting Point 158-160ºC
Molecular Formula C22H28O3
Molecular Weight 340.456
Flash Point 237.6±30.2 °C
Exact Mass 340.203857
PSA 43.37000
LogP 2.99
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.581

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TU3493000
CHEMICAL NAME :
Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17-alpha)-
CAS REGISTRY NUMBER :
976-71-6
BEILSTEIN REFERENCE NO. :
0046602
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C22-H28-O3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ATDAEI Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990- Volume(issue)/page/year: 1,36,1990
Symbol GHS08 GHS09
GHS08, GHS09
Signal Word Warning
Hazard Statements H351-H411
Precautionary Statements P280
Hazard Codes Xn,N
Risk Phrases 40-51/53
Safety Phrases 36/37-61
RIDADR UN 3077 9 / PGIII
HS Code 29329990
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.